GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia
about
C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral strokePiecing together the humoral and cellular mechanisms of immune thrombocytopeniaSimian Immunodeficiency Virus Infection of Chimpanzees (Pan troglodytes) Shares Features of Both Pathogenic and Non-pathogenic Lentiviral InfectionsMolecular mimicry and immune thrombocytopeniaRole of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopeniaMolecular characterization of virus-induced autoantibody responses.Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia.Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: systemic lupus erythematosus, hepatitis-cirrhosis, and HIV-1 infection by platelet and serum immunological measurements.Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients.Anti-platelet antibodies associated with the Canale-Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purpura patients.Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway.Autoimmune thrombocytopenias.Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase.Fine specificity of drug-dependent antibodies reactive with a restricted domain of platelet GPIIIARisk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy.Dissolution of arterial platelet thrombi in vivo with a bifunctional platelet GPIIIa49-66 ligand which specifically targets the platelet thrombusSpecific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66Pathophysiology and therapeutic options in primary immune thrombocytopenia.Immune thrombocytopenia: no longer 'idiopathic'.Crosstalk between Platelets and the Immune System: Old Systems with New DiscoveriesIntegrin GPIIIa49-57 is the pivotal switch controlling platelet fragmentation.Characterization of HIV-1-specific antibodies and HIV-1-crossreactive antibodies to platelets in HIV-1-infected haemophiliac patients.Immune thrombocytopenic purpura might be an early hematologic manifestation of undiagnosed human immunodeficiency virus infection.Selected biochemical and hematological abnormalities in Nigerians with human immunodeficiency virus and hepatitis C virus coinfection.
P2860
Q24310892-C7C5B353-36CC-42E7-8A8E-19A29E76069FQ27024841-0E4B8E5C-3D35-46E5-93F8-2881C3FC0C33Q27317328-5B0BAA89-E996-40AA-8B05-A9F3AA2DA9FCQ27488341-A0BC5E9E-4E05-487F-B09A-97CC807BA74AQ27488342-7949126A-231C-4151-87EC-556B330E3A08Q31110185-8E6E309F-F7EF-4D53-B13F-352A94BEE8BFQ31154319-BEC36D03-1665-4718-9635-270B7C37F281Q33330532-8AB61A92-4612-4019-A667-E0853D44C3CCQ33332866-2D1AF0A6-284B-485F-871C-3B184FBC2E1DQ33341289-F8BB2085-A91E-4A21-8BD9-630C804638EAQ33360225-38141888-CF79-4C33-97A5-41A01D4CC334Q33363539-BA9A340D-5E3D-4EA7-8EB2-4B064B5A0260Q33375459-B3BB0962-2627-4116-AA90-470030D41579Q33377139-441F4545-20F4-4684-98E4-81E231DE3084Q33386133-D9455BAC-5D3E-46BB-AE6A-4A1061B5A0ABQ33389941-89562B75-A51C-4819-B0C7-4442DA42B2F3Q33391806-7107FC42-EF51-424D-8012-EC1342FF1253Q33393732-64AEBBAF-A9B4-422E-AC31-4468BB9C5D18Q33395624-9FFEE5A6-E1AD-4427-B0D1-EF7983B28DF2Q33403517-56F24232-278C-44B0-AB12-AB019161BC5BQ33421433-590F4D4B-F6F7-44C7-B8F6-1CCB6E58574BQ33504907-D89C8F43-EDAD-4193-8856-5A6CAA013BEAQ39452896-D9B90050-51EE-4399-8072-DF62C25FFB79Q42140762-98E433C4-B666-44DA-AC2F-37192D335268
P2860
GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
GPIIIa-(49-66) is a major path ...... d immunologic thrombocytopenia
@ast
GPIIIa-(49-66) is a major path ...... d immunologic thrombocytopenia
@en
type
label
GPIIIa-(49-66) is a major path ...... d immunologic thrombocytopenia
@ast
GPIIIa-(49-66) is a major path ...... d immunologic thrombocytopenia
@en
prefLabel
GPIIIa-(49-66) is a major path ...... d immunologic thrombocytopenia
@ast
GPIIIa-(49-66) is a major path ...... d immunologic thrombocytopenia
@en
P2093
P2860
P356
P1476
GPIIIa-(49-66) is a major path ...... d immunologic thrombocytopenia
@en
P2093
P2860
P304
P356
10.1073/PNAS.94.14.7589
P407
P577
1997-07-01T00:00:00Z